Page last updated: 2024-09-04

olmesartan and Cirrhosis

olmesartan has been researched along with Cirrhosis in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (38.46)29.6817
2010's8 (61.54)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bae, EH; Choi, HS; Kim, CS; Kim, IJ; Kim, SW; Ma, SK; Scholey, JW; Suh, SH1
Cui, X; Fu, M; Ge, J; Hu, K; Liao, J; Sun, A; Xu, J; Zhou, J; Zhu, H; Zou, Y1
Chong, L; Chu, M; Huang, Y; Li, Y; Mei, L; Wu, L; Yang, X1
Ichikawa, H; Kimura, Y; Kinjo, T; Narita, I; Nishizaki, K; Okumura, K; Osanai, T; Tanaka, M; Tanno, T; Tomita, H1
Cheng, XW; Izawa, H; Kim, W; Kobayashi, M; Kuzuya, M; Murohara, T; Nagata, K; Nishizawa, T; Obata, K; Okumura, K; Sasaki, T; Sato, K; Shi, GP; Yamada, T; Yokota, M1
Dong, YF; Ichijo, H; Kataoka, K; Kim-Mitsuyama, S; Matsuba, S; Ogawa, H; Tokutomi, Y; Yamamoto, E; Yamashita, T1
Fukamizu, A; Honjo, K; Inaba, S; Ishida, J; Nakamura, S; Sakairi, A; Sugiyama, F; Yagami, K1
Futai, R; Ito, T; Kawanishi, Y; Kitaura, Y; Terasaki, F1
Geot, WM; Horikoshi, S; Suzuki, Y; Takahashi, H; Tanifuji, C; Tomino, Y1
Kato, M; Mizuno, M; Sada, T; Terashima, H; Tsuchida, H; Yasumo, H1
Chen, R; Eisner, C; Hu, X; Huang, Y; Kopp, JB; Leelahavanichkul, A; Mizel, D; Schnermann, J; Star, RA; Wright, EC; Yan, Q; Yuen, PS; Zhou, H1
Hatipoglu, FO; Hirohata, S; Iwamoto, M; Kusachi, S; Miyoshi, T; Ninomiya, Y; Ogawa, H; Ohtsuki, T; Shinohata, R; Yamamoto, K1
Ge, J; Guo, J; Jiang, G; Li, L; Wang, S; Wu, J; You, J; Zou, Y1

Trials

1 trial(s) available for olmesartan and Cirrhosis

ArticleYear
Olmesartan ameliorates myocardial function independent of blood pressure control in patients with mild-to-moderate hypertension.
    Heart and vessels, 2009, Volume: 24, Issue:4

    Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Biomarkers; Blood Pressure; C-Reactive Protein; Calcium Channel Blockers; Echocardiography, Doppler, Color; Female; Fibrosis; Humans; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Inflammation; Male; Middle Aged; Myocardium; Severity of Illness Index; Tetrazoles; Time Factors; Treatment Outcome; Ventricular Function, Left

2009

Other Studies

12 other study(ies) available for olmesartan and Cirrhosis

ArticleYear
Olmesartan Attenuates Kidney Fibrosis in a Murine Model of Alport Syndrome by Suppressing Tubular Expression of TGFβ.
    International journal of molecular sciences, 2019, Aug-06, Volume: 20, Issue:15

    Topics: Angiotensin-Converting Enzyme 2; Animals; Antihypertensive Agents; Apoptosis; Biomarkers; Biopsy; Disease Models, Animal; Fibrosis; Gene Expression Regulation; Imidazoles; Kidney Tubules; Mice; Mice, Knockout; Nephritis, Hereditary; Peptidyl-Dipeptidase A; ras Proteins; Tetrazoles; Transforming Growth Factor beta; Treatment Outcome

2019
Olmesartan attenuates cardiac hypertrophy and improves cardiac diastolic function in spontaneously hypertensive rats through inhibition of calcineurin pathway.
    Journal of cardiovascular pharmacology, 2014, Volume: 63, Issue:3

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Calcineurin; Cardiomegaly; Diastole; Down-Regulation; Fibrosis; Heart Rate; Hypertension; Imidazoles; Male; NFATC Transcription Factors; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles

2014
Olmesartan ameliorates pressure overload-induced cardiac remodeling through inhibition of TAK1/p38 signaling in mice.
    Life sciences, 2016, Jan-15, Volume: 145

    Topics: Animals; Antihypertensive Agents; Blood Pressure; Cells, Cultured; Fibroblasts; Fibrosis; Heart; Imidazoles; Male; MAP Kinase Kinase Kinases; Mice; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Rats; Signal Transduction; Tetrazoles; Transforming Growth Factor beta1

2016
Olmesartan Inhibits Cardiac Hypertrophy in Mice Overexpressing Renin Independently of Blood Pressure: Its Beneficial Effects on ACE2/Ang(1-7)/Mas Axis and NADPH Oxidase Expression.
    Journal of cardiovascular pharmacology, 2016, Volume: 67, Issue:6

    Topics: Animals; Blood Pressure; Cardiomegaly; Fibrosis; Gene Expression; Hydralazine; Imidazoles; Male; Mice; Myocytes, Cardiac; NADPH Oxidases; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Renin; Renin-Angiotensin System; Signal Transduction; Tetrazoles

2016
Superoxide-dependent cathepsin activation is associated with hypertensive myocardial remodeling and represents a target for angiotensin II type 1 receptor blocker treatment.
    The American journal of pathology, 2008, Volume: 173, Issue:2

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Cathepsins; Cells, Cultured; Fibrosis; Heart Failure; Humans; Hypertension; Imidazoles; Leucine; Myocardium; Myocytes, Cardiac; NADPH Oxidases; Rats; Rats, Inbred Dahl; Receptor, Angiotensin, Type 1; Sodium Chloride; Superoxides; Tetrazoles; Ventricular Remodeling

2008
Olmesartan prevents cardiovascular injury and hepatic steatosis in obesity and diabetes, accompanied by apoptosis signal regulating kinase-1 inhibition.
    Hypertension (Dallas, Tex. : 1979), 2008, Volume: 52, Issue:3

    Topics: Adiponectin; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Blood Pressure; Body Weight; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Eating; Endothelium, Vascular; Fatty Liver; Fibrosis; Imidazoles; Insulin Resistance; Male; MAP Kinase Kinase Kinase 5; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; NADPH Oxidases; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Obesity; Reactive Oxygen Species; Signal Transduction; Tetrazoles; Transforming Growth Factor beta1

2008
Angiotensin type 1 receptor blockade prevents cardiac remodeling in mice with pregnancy-associated hypertension.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2008, Volume: 31, Issue:12

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Cardiomegaly; Disease Models, Animal; Female; Fibrosis; Hypertension, Pregnancy-Induced; Imidazoles; Male; Mice; Mice, Transgenic; Myocardium; Pregnancy; Receptor, Angiotensin, Type 1; Signal Transduction; Tetrazoles; Ventricular Remodeling

2008
Beneficial effects of combination therapy with olmesartan and azelnidipine in murine polycystic kidneys.
    Kidney & blood pressure research, 2009, Volume: 32, Issue:4

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Azetidinecarboxylic Acid; Blotting, Western; Calcium Channel Blockers; Dihydropyridines; Drug Synergism; Drug Therapy, Combination; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Imidazoles; Immunohistochemistry; Kidney; Mice; NADPH Oxidases; Nitric Oxide Synthase Type III; Polycystic Kidney Diseases; Tetrazoles

2009
A sensitive short-term evaluation of antifibrotic effects using newly established type I collagen reporter transgenic rats.
    American journal of physiology. Renal physiology, 2010, Volume: 299, Issue:4

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzamides; Collagen; Collagen Type I; Collagen Type I, alpha 1 Chain; Dioxoles; Disease Models, Animal; Fibrosis; Genes, Reporter; Hydroxyproline; Imidazoles; Kidney; Luciferases; Male; Protein Serine-Threonine Kinases; Rats; Rats, Transgenic; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Sensitivity and Specificity; Tetrazoles; Ureteral Obstruction

2010
Angiotensin II overcomes strain-dependent resistance of rapid CKD progression in a new remnant kidney mouse model.
    Kidney international, 2010, Volume: 78, Issue:11

    Topics: Albuminuria; Anemia; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Chronic Disease; Desoxycorticosterone; Disease Models, Animal; Disease Progression; Fibrosis; Genetic Predisposition to Disease; Glomerulonephritis; Heart Diseases; Hydralazine; Hypertension; Imidazoles; Infusion Pumps, Implantable; Infusions, Subcutaneous; Kidney; Kidney Diseases; Male; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Nephrectomy; Sodium Chloride, Dietary; Species Specificity; Telemetry; Tetrazoles; Time Factors; X-Ray Microtomography

2010
Connective tissue growth factor induction in a pressure-overloaded heart ameliorated by the angiotensin II type 1 receptor blocker olmesartan.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2010, Volume: 33, Issue:12

    Topics: Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Cardiomegaly; Connective Tissue Growth Factor; Echocardiography; Enzyme-Linked Immunosorbent Assay; Fibrosis; Heart; Hydralazine; Imidazoles; Immunohistochemistry; Male; Myocardium; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Tetrazoles; Transforming Growth Factor beta1

2010
Olmesartan attenuates cardiac remodeling through DLL4/Notch1 pathway activation in pressure overload mice.
    Journal of cardiovascular pharmacology, 2013, Volume: 61, Issue:2

    Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Calcium-Binding Proteins; Dipeptides; Disease Models, Animal; Fibrosis; Hypertrophy, Left Ventricular; Imidazoles; Intracellular Signaling Peptides and Proteins; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Microcirculation; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Receptor, Notch1; Tetrazoles; Up-Regulation; Ventricular Dysfunction, Left; Ventricular Remodeling

2013